Soluble Molecules as Biological Markers in Hodgkin's Disease
- 1 January 1997
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 26 (sup1), 99-105
- https://doi.org/10.3109/10428199709058606
Abstract
Hodgkin's disease (HD) is characterised by a complex architectural and functional derangement of involved tissues. The interactions between neoplastic cells and the heterogeneous microenvironment lead to the expression and release of different cellular messengers [cytokines, soluble (s) forms of cytokine receptors and other membrane-associated molecules] which can be detected in the circulation and evaluated as biological markers. We and others investigated several of these molecules looking for their possible role as diagnostic or prognostic parameters in patients with HD. We update here the results of serum determination of sIL-2Ralpha, sCD8, sICAM-1, sTNFRs, and sCD30 in a large series of cases from our institution. We found that their levels are generally increased at presentation and during the active phase of the disease. They correlate with stage and clinical aggressiveness and have some prognostic implication. However, we were unable to demonstrate a prognostic usefulness for their detection, with the exception for sCD30 which was found to directly correlate with disease spread and burden at presentation and, most importantly, to have an independent prognostic significance. The prognostic significance of sCD30 might derive from a crucial involvement of this molecule in the pathophysiology of HD.Keywords
This publication has 19 references indexed in Scilit:
- CD30, Th2 cytokines and HIV infections: a complex and fascinating linkImmunology Today, 1995
- Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's diseaseInternational Journal of Clinical and Laboratory Research, 1995
- CD30 and type 2 T helper (Th2) responsesJournal of Leukocyte Biology, 1995
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- Serum intercellular adhesion molecule-1 in childhood malignancyBlood, 1993
- Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeCancer, 1993
- The interleukin-2/interleukin-2 receptor system: structural, immunological, and clinical featuresInternational Journal of Clinical and Laboratory Research, 1992
- Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's diseaseBlood, 1991
- Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcomeBlood, 1989
- Soluble interleukin-2 receptors in the serum of patients with Hodgkin's diseaseBritish Journal of Cancer, 1987